Quote:

---

why bring that on when Leronlimab alone can basically handle the various symptoms without any negative side effects.


Read More: https://investorshangout.com/post/newpost/605...z6MoLSl9Cd

---

This trial will prove that. I am a bit surprised that Gilead has agreed to this, because the structure of this trial will, without a doubt show which drub is better.

I have to imagine that they know our trials are going to catapult us into the lead, and they are hoping that a combination use keeps them relevant.